A recently issued white paper by Lodestar CEO Tom Nelson has been selected as an Editor’s Pick at CustomerThink, the world’s the world's largest online community dedicated to customer-centric business strategy....Read More

Lodestar has recently extended its four-year partnership with IBM Watson Health by conducting an assessment of emerging partnerships and partnership models across the healthcare/life sciences landscape, both in the U.S. and internationally....Read More

Lodestar Advisory Partners has just completed a customer validation of a Jobs- To-Be-Done framework for Shipley’s Energy Objective B2B brokerage division. Based on Anthony Ulwick’s well-known methodology, JTBD requires a company team to first establish or hypothesize all of the primary, secondary, and tertiary “jobs” a prospective buyer is attempting to complete in an integrated framework and then, second, conduct external customer research to validate the “goodness of fit” of the framework. ...Read More

The Lodestar White Paper Series™ has just been expanded with the addition of 10 Reasons Why Smart Companies Invest in Formal Technology Scouting....Read More

As it does every year, Lodestar associates will attend a wide variety of trade shows and events in 2019 to represent the interests of our clients and to stay current on the latest developments and trends across multiple industry verticals...Read More

Lodestar associates recently attended Inspire, an annual gathering of over 12,000 global Microsoft business partners in Las Vegas, NV on July 16-18, 2018....Read More

Princeton, NJ, June 1, 2018 – Lodestar Advisory Partners has announced the release of The Strategic Partnership Performance Suite℠, a platform of products, tools, resources and consulting services to help clients more effectively build, manage, and optimize partnerships, alliances, supplier/distributor pipelines, and other forms of inter-company collaborative relationships....Read More

Princeton, NJ, May 16, 2018 – Lodestar Advisory Partners recently completed a comprehensive and confidential assessment of the U.S. Genomic Medicine marketplace for a client at the juncture of leading-edge healthcare information technology, artificial intelligence, and genomic testing interpretation.  The study looked at current general trends and future projections, but also provided in-depth competitive benchmarking of fourteen leading companies in diagnostic genomics testing and patient treatment planning....Read More